This site is intended for healthcare professionals

Phase III KEYNOTE-775/Study 309 trial of Keytruda + Lenvima meets endpoints in endometrial cancer.- Merck Inc and Eisai

Read time: 1 mins
Last updated:20th Mar 2021
Published:20th Mar 2021
Condition: Endometrial Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest